Wells Fargo
JAZZ icon

Wells Fargo’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wells Fargo’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-22,500
Closed -$264K – 6553
2019
Q3 		$264K Hold
22,500
– – ﹤0.01% 4791
2019
Q2 		$168K Buy
+22,500
New +$3.02M ﹤0.01% 5067

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Wells Fargo's JAZZ Position: Q2 2026 in Review

Wells Fargo increased its Jazz Pharmaceuticals (JAZZ) stake by 57% in Q2 2026, buying an estimated $8.53M and bringing the position to 107,422 shares worth $25.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

Wells Fargo first reported a position in JAZZ in Q2 2013 and has held it in 53 quarters since. The position peaked at $308M in Q2 2014. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Wells Fargo held 107,422 shares of Jazz Pharmaceuticals worth $25.9M as of Q2 2026.
  • Wells Fargo bought 38,934 Jazz Pharmaceuticals shares in Q2 2026, an estimated $8.53M.
  • Jazz Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1442 holding.
  • Wells Fargo first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Wells Fargo's Jazz Pharmaceuticals position peaked at $308M in Q2 2014.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.